Having trouble accessing articles? Reset your cache.

Erbitux cetuximab: Phase III data

The open-label, international Phase III NORDIC VII trial in 566 patients showed that there were no significant differences between

Read the full 197 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE